BRIEF-Tracon Pharmaceuticals announces a strategic licensing collaboration for two Janssen Oncology assets and a $5 mln equity investment from Johnson & Johnson Innovation - JJDC Inc
September 28, 2016 at 08:21 AM EDT
* Tracon Pharmaceuticals announces a strategic licensing collaboration for two Janssen Oncology assets and a $5 million equity investment from Johnson & Johnson Innovation - JJDC, Inc.
